Femoral bone mineral density at the time of hip fracture is higher in women with versus without type 2 diabetes mellitus: a cross-sectional study.
Diabetes mellitus
Dual-energy x-ray absorptiometry
Hip fractures
Osteoporosis
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
10 Jun 2023
10 Jun 2023
Historique:
received:
15
12
2022
accepted:
26
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
9
6
2023
Statut:
aheadofprint
Résumé
To compare femoral bone mineral density (BMD) levels in hip-fracture women with versus without type 2 diabetes mellitus (T2DM). We hypothesized that BMD levels could be higher in the women with T2DM than in controls and we aimed to quantify the BMD discrepancy associated with the presence of T2DM. At a median of 20 days after the occurrence of an original hip fracture due to fragility we measured BMD by dual-energy x-ray absorptiometry at the non-fractured femur. We studied 751 women with subacute hip fracture. Femoral BMD was significantly higher in the 111 women with T2DM than in the 640 without diabetes: mean T-score between-group difference was 0.50, (95% CI from 0.30 to 0.69, P < 0.001). The association between the presence of T2DM and femoral BMD persisted after adjustment for age, body mass index, hip-fracture type, neurologic diseases, parathyroid hormone, 25-hydroxyvitamin D and estimated glomerular filtration rate (P < 0.001). For a woman without versus with T2DM, the adjusted odds ratio to have a femoral BMD T-score below the threshold of - 2.5 was 2.13 (95% CI from 1.33 to 3.42, P = 0.002). Fragility fractures of the hip occurred in women with T2DM at a femoral BMD level higher than in control women. In the clinical assessment of fracture risk, we support the adjustment based on the 0.5 BMD T-score difference between women with and without T2DM, although further data from robust longitudinal studies is needed to validate the BMD-based adjustment of fracture risk estimation.
Identifiants
pubmed: 37296371
doi: 10.1007/s40618-023-02122-3
pii: 10.1007/s40618-023-02122-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
Références
Chen W, Mao M, Fang J, Xie Y, Rui Y (2022) Fracture risk assessment in diabetes mellitus. Front Endocrinol (Lausanne) 13:961761. https://doi.org/10.3389/fendo.2022.961761
doi: 10.3389/fendo.2022.961761
pubmed: 36120431
Jiang N, Xia W (2018) Assessment of bone quality in patients with diabetes mellitus. Osteoporos Int 29:1721–1736. https://doi.org/10.1007/s00198-018-4532-7
doi: 10.1007/s00198-018-4532-7
pubmed: 29736760
Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, IOF Bone and Diabetes Working Group (2017) Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 13:208–219. https://doi.org/10.1038/nrendo.2016.153
doi: 10.1038/nrendo.2016.153
pubmed: 27658727
Hofbauer LC, Busse B, Eastell R et al (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol 10:207–220. https://doi.org/10.1016/S2213-8587(21)00347-8
doi: 10.1016/S2213-8587(21)00347-8
pubmed: 35101185
Khosla S, Samakkarnthai P, Monroe DG, Farr JN (2021) Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus. Nat Rev Endocrinol 17:685–697. https://doi.org/10.1038/s41574-021-00555-5
doi: 10.1038/s41574-021-00555-5
pubmed: 34518671
pmcid: 8605611
Ferrari SL, Abrahamsen B, Napoli N, Bone and Diabetes Working Group of IOF et al (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29:2585–2596. https://doi.org/10.1007/s00198-018-4650-2
doi: 10.1007/s00198-018-4650-2
pubmed: 30066131
pmcid: 6267152
Liu J, Curtis EM, Cooper C, Harvey NC (2019) State of the art in osteoporosis risk assessment and treatment. J Endocrinol Invest 42:1149–1164. https://doi.org/10.1007/s40618-019-01041-6
doi: 10.1007/s40618-019-01041-6
pubmed: 30980341
pmcid: 6751157
Agarwal A, Leslie WD, Nguyen TV, Morin SN, Lix LM, Eisman JA (2022) Performance of the Garvan Fracture Risk Calculator in individuals with diabetes: A registry-based cohort study. Calcif Tissue Int 110:658–665. https://doi.org/10.1007/s00223-021-00941-1
doi: 10.1007/s00223-021-00941-1
pubmed: 34994831
Giangregorio LM, Leslie WD, Lix LM et al (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27:301–308. https://doi.org/10.1002/jbmr.556
doi: 10.1002/jbmr.556
pubmed: 22052532
Maggi S, Siviero P, Wetle T, Besdine RW, Saugo M, Crepaldi G, Hip Fracture Study Group (2010) A multicenter survey on profile of care for hip fracture: predictors of mortality and disability. Osteoporos Int 21:223–231. https://doi.org/10.1007/s00198-009-0936-8
doi: 10.1007/s00198-009-0936-8
pubmed: 19415372
Abraham DS, Barr E, Ostir GV, Hebel JR, Golden J, Gruber-Baldini AL (2019) Residual disability, mortality, and nursing home placement after hip fracture over 2 decades. Arch Phys Med Rehabil 100:874–882. https://doi.org/10.1016/j.apmr.2018.10.008
doi: 10.1016/j.apmr.2018.10.008
pubmed: 30391413
Schousboe JT, Morin SN, Kline GA, Lix LM, Leslie WD (2022) Differential risk of fracture attributable to type 2 diabetes mellitus according to skeletal site. Bone 154:116220. https://doi.org/10.1016/j.bone.2021.116220
doi: 10.1016/j.bone.2021.116220
pubmed: 34571204
Schwartz AV, Vittinghoff E, Bauer DC, Study of Osteoporotic Fractures (SOF) Research Group; Osteoporotic Fractures in Men (MrOS) Research Group; Health, Aging, and Body Composition (Health ABC) Research Group et al (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192. https://doi.org/10.1001/jama.2011.715
doi: 10.1001/jama.2011.715
pubmed: 21632482
pmcid: 3287389
Hu L, Li T, Zou Y, Yin XL, Gan H (2021) The clinical value of the RA-adjusted fracture risk assessment tool in the fracture risk prediction of patients with type 2 diabetes mellitus in China. Int J Gen Med 14:327–333. https://doi.org/10.2147/IJGM.S296399
doi: 10.2147/IJGM.S296399
pubmed: 33542649
pmcid: 7853630
Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry. J Bone Miner Res 33:1923–1930. https://doi.org/10.1002/jbmr.3538
doi: 10.1002/jbmr.3538
pubmed: 29953670
Chiodini I, Gaudio A, Palermo A et al (2021) Management of bone fragility in type 2 diabetes: perspective from an interdisciplinary expert panel. Nutri Metab Cardiovasc Dis 31:2210–2233. https://doi.org/10.1016/j.numecd.2021.04.014
doi: 10.1016/j.numecd.2021.04.014
Wang H, Ba Y, Xing Q, Du JL (2019) Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open 9:e024067. https://doi.org/10.1136/bmjopen-2018-024067
doi: 10.1136/bmjopen-2018-024067
pubmed: 30610024
pmcid: 6326306
Koromani F, Oei L, Shevroja E et al (2020) Vertebral fractures in individuals with type 2 diabetes: More than skeletal complications alone. Diabetes Care 43:137144. https://doi.org/10.2337/dc19-0925
doi: 10.2337/dc19-0925
Shan PF, Wu XP, Zhang H, Cao XZ, Yuan LQ, Liao EY (2011) Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus. J Endocrinol Invest 34:190–196. https://doi.org/10.1007/BF03347065
doi: 10.1007/BF03347065
pubmed: 20808073
Vilaca T, Walsh J, Eastell R (2019) Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures. Osteoporos Int 30:135–143. https://doi.org/10.1007/s00198-018-4717-0
doi: 10.1007/s00198-018-4717-0
pubmed: 30306223
Caffarelli C, Alessi C, Nuti R, Gonnelli S (2014) Divergent effects of obesity on fragility fractures. Clin Interv Aging 9:1629–1636. https://doi.org/10.2147/CIA.S64625
doi: 10.2147/CIA.S64625
pubmed: 25284996
pmcid: 4181449
Napoli N, Conte C, Pedone C et al (2019) Effect of insulin resistance on BMD and fracture risk in older adults. J Clin Endocrinol Metab 104:3303–3310. https://doi.org/10.1210/jc.2018-02539
doi: 10.1210/jc.2018-02539
pubmed: 30802282
pmcid: 6584125
Komorita Y, Iwase M, Fujii H et al (2017) Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetologia 60:1922–1930. https://doi.org/10.1007/s00125-017-4369-1
doi: 10.1007/s00125-017-4369-1
pubmed: 28721438
Nakamura Y, Nakano M, Suzuki T et al (2020) Two adipocytokines, leptin and adiponectin, independently predict osteoporotic fracture risk at different bone sites in postmenopausal women. Bone 137:115404. https://doi.org/10.1016/j.bone.2020.115404
doi: 10.1016/j.bone.2020.115404
pubmed: 32360897
Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A (2003) Fat body mass, leptin and femur bone mineral density in hip-fractured women. J Endocrinol Invest 26:1180–1185. https://doi.org/10.1007/BF03349154
doi: 10.1007/BF03349154
pubmed: 15055469
Cianferotti L, Cipriani C, Corbetta S et al (2023) Bone quality in endocrine diseases: determinants and clinical relevance. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02056-w
doi: 10.1007/s40618-023-02056-w
pubmed: 37031450
Ho-Pham LT, Nguyen TV (2019) Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence. Osteoporos Int 30:2079–2085. https://doi.org/10.1007/s00198-019-05053-z
doi: 10.1007/s00198-019-05053-z
pubmed: 31214749
Haeri NS, Kotlarczyk MP, Perera S, Greenspan SL (2022) Diabetes mellitus is associated with poor bone microarchitecture in older adults residing in long-term care facilities. J Osteoporos. https://doi.org/10.1155/2022/2522014
doi: 10.1155/2022/2522014
pubmed: 36578470
pmcid: 9792231
Kim JH, Choi HJ, Ku EJ et al (2015) Trabecular bone score as an indicator for skeletal deterioration in diabetes. J Clin Endocrinol Metab 100:475–482. https://doi.org/10.1210/jc.2014-2047
doi: 10.1210/jc.2014-2047
pubmed: 25368976
Dhaliwal R, Cibula D, Ghosh C, Weinstock RS, Moses AM (2014) Bone quality assessment in type 2 diabetes mellitus. Osteoporos Int 25:1969–1973. https://doi.org/10.1007/s00198-014-2704-7
doi: 10.1007/s00198-014-2704-7
pubmed: 24718377
Shieh A, Greendale GA, Cauley JA et al (2022) Prediabetes and insulin resistance are associated with lower bone score (TBS): cross-sectional results from the study of women’s health across the nation TBS study. Osteoporos Int 33:1365–1372. https://doi.org/10.1007/s00198-022-06325-x
doi: 10.1007/s00198-022-06325-x
pubmed: 35178609
pmcid: 9106606
Delbari N, Rajaei A, Oroei M, Ahmadzadeh A, Farsad F (2021) A comparison between femoral neck and LS-BMD with LS-TBS in T2DM patients: a case control study. BMC Musculoskel Dis 22:582. https://doi.org/10.1186/s12891-021-04471-7
doi: 10.1186/s12891-021-04471-7
Chuang TL, Chuang MH, Wang YF, Koo M (2022) Comparison of Trabecular Bone Score-adjusted fracture risk assessment (TBS-FRAX) and FRAX tools for identification of high fracture risk among Taiwanese adults aged 50 to 90 years with or without prediabetes and diabetes. Medicina (Kaunas) 58:1766. https://doi.org/10.3390/medicina58121766
doi: 10.3390/medicina58121766
pubmed: 36556968
Leslie WD, Aubry-Rozier B, Lamy O, Hans D, Manitoba Bone Density P (2013) TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab 98:602–609. https://doi.org/10.1210/jc.2012-3118
doi: 10.1210/jc.2012-3118
pubmed: 23341489
Palomo T, Dreyer P, Muszkat P et al (2022) Effect of soft tissue noise on trabecular bone score in postmenopausal women with diabetes: a cross sectional study. Bone 157:116339. https://doi.org/10.1016/j.bone.2022.116339
doi: 10.1016/j.bone.2022.116339
pubmed: 35051679
Caffarelli C, Tomai Pitinca MD, Al Refaie A, Ceccarelli E, Gonnelli S (2022) Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging Clin Exp Res 34:121–127. https://doi.org/10.1007/s40520-021-01889-
doi: 10.1007/s40520-021-01889-
pubmed: 34050917
Behanova M, Haschka J, Zwerina J et al (2021) The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality. Eur J Endocrinol 184:627–636. https://doi.org/10.1530/EJE-20-1155
doi: 10.1530/EJE-20-1155
pubmed: 33630752
Shen Q, Ma Y (2022) Impact of diabetes mellitus on risk of major complications after hip fracture: a systematic review and meta-analysis. Diabetol Metab Syndr 14:51. https://doi.org/10.1186/s13098-022-00821-0
doi: 10.1186/s13098-022-00821-0
pubmed: 35414035
pmcid: 9003957
Sheu A, Bliuc D, Tran T, White CP, Center JR (2022) Fractures in type 2 diabetes confer excess mortality: the Dubbo osteoporosis epidemiology study. Bone 159:116373. https://doi.org/10.1016/j.bone.2022.116373
doi: 10.1016/j.bone.2022.116373
pubmed: 35231635
Giovanelli L, Aresta C, Favero V et al (2021) Hidden hypercortisolism: a too frequently neglected clinical condition. J Endocrinol Invest 44:1581–1596. https://doi.org/10.1007/s40618-020-01484-2
doi: 10.1007/s40618-020-01484-2
pubmed: 33394454
Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S (2021) Sarcopenia, frailty and type 2 diabetes mellitus (Review). Mol Med Rep 24:854. https://doi.org/10.3892/mmr.2021.12494
doi: 10.3892/mmr.2021.12494
pubmed: 34651658
Di Monaco M, Castiglioni C, Bardesono F, Freiburger M, Milano E, Massazza G (2022) Is sarcopenia associated with osteoporosis? A cross-sectional study of 262 women with hip fracture. Eur J Phys Rehabil Med 58:638–645. https://doi.org/10.23736/S1973-9087.22.07215-X
doi: 10.23736/S1973-9087.22.07215-X
pubmed: 35412037
Mukka S, Knutsson B, Krupic F, Sayed-Noor AS (2017) The influence of cognitive status on outcome and walking ability after hemiarthroplasty for femoral neck fracture: a prospective cohort study. Eur J Orthop Surg Traumatol 27:653–658. https://doi.org/10.1007/s00590-016-1873-9
doi: 10.1007/s00590-016-1873-9
pubmed: 27796582
Soderqvist A, Ekstrom W, Ponzer S et al (2009) Prediction of mortality in elderly patients with hip fractures: a two-year prospective study of 1,944 patients. Gerontology 55:496–504. https://doi.org/10.1159/000230587
doi: 10.1159/000230587
pubmed: 19628932
Morghen S, Gentile S, Ricci E, Guerini F, Bellelli G, Trabucchi M (2011) Rehabilitation of older adults with hip fracture: cognitive function and walking abilities. J Am Geriatr Soc 59:1497–1502. https://doi.org/10.1111/j.1532-5415.2011.03496.x
doi: 10.1111/j.1532-5415.2011.03496.x
pubmed: 21797828
Di Monaco M, Castiglioni C, Di Carlo S et al (2019) Classes of vitamin D status and functional outcome after hip fracture: a prospective, short-term study of 1350 inpatients. Eur J Phys Rehabil Med 55:56–62. https://doi.org/10.23736/S1973-9087.18.05191-2
doi: 10.23736/S1973-9087.18.05191-2
pubmed: 29904045
Bardesono F, Trombetta S, Gullone L et al (2022) A screening test is not enough to define the prognostic role of cognitive impairment after hip fracture: a short-term prospective study. Aging Clin Exp Res 34:2977–2984. https://doi.org/10.1007/s40520-022-02233-6
doi: 10.1007/s40520-022-02233-6
pubmed: 36057082
Li S, Zhang J, Zheng H, Wang X, Liu Z, Sun T (2019) Prognostic role of serum albumin, total lymphocyte count, and Mini Nutritional Assessment on outcomes after geriatric hip fracture surgery: a meta-analysis and systematic review. J Arthroplasty 34:1287–1296. https://doi.org/10.1016/j.arth.2019.02.003
doi: 10.1016/j.arth.2019.02.003
pubmed: 30852065